| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Health insurer stocks fell after the Senate ended the shutdown without extending ACA subsidies, delaying the decision to Decemb...
Wall Street rebounded on Monday, recovering part of last week's steep losses as investors grew more confident about risk as...
Jefferies analyst Brian Tanquilut maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $485 to $525.
UBS analyst Andrew Mok maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $495 to $525.
B of A Securities analyst Joanna Gajuk maintains HCA Healthcare (NYSE:HCA) with a Neutral and raises the price target from $...
Goldman Sachs analyst Scott Fidel maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $470 to $...
TD Cowen analyst Ryan Langston maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $380 to $490.